Table 1 Baseline demographics and clinical characteristics of enrolled patients
Variable | Value |
|---|---|
number of patients | 106 |
Age, years | 67 (61–73) |
PSA, ng/ml | 11.48 (7.73–17.45) |
TAUS PV, ml | 48.5 ± 20.2 |
MRI PV, ml | 44.4 ± 15.4 |
Specimen volume, ml | 46.1 ± 18.3 |
Pathological T stage | |
T2a | 11 (10.4) |
T2b | 13 (12.3) |
T2c | 56 (52.8) |
T3a | 21 (19.8) |
T3b | 5 (4.7) |
Surgical Gleason grade group | |
1 (3 + 3) | 8 (7.5) |
2 (3 + 4) | 22 (20.8) |
3 (4 + 3) | 27 (25.5) |
4 (8) | 35 (33.0) |
5 (9–10) | 14 (13.2) |